{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
Oncopig Cancer Model by Sus Clinicals, Inc
(2021)
Source URL:
First approved in 2021
Source:
Oncopig Cancer Model by Sus Clinicals, Inc
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
OssaPig-NF-NF1(NS) Miniature Swine by Recombinetics, Inc.
(2021)
Source URL:
First approved in 2021
Source:
OssaPig-NF-NF1(NS) Miniature Swine by Recombinetics, Inc.
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NADA141542
(2021)
Source URL:
First approved in 2021
Source:
NADA141542
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
OssaPig-LD-NASH Miniature Swine by Recobimbinetics, Inc.
(2020)
Source URL:
First approved in 2020
Source:
OssaPig-LD-NASH Miniature Swine by Recobimbinetics, Inc.
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
ExeGen CLN2 miniswine by Exemplar Genetics LLC (dba Precigen Exemplar)
(2020)
Source URL:
First approved in 2020
Source:
ExeGen CLN2 miniswine by Exemplar Genetics LLC (dba Precigen Exemplar)
Source URL:
Class:
STRUCTURALLY DIVERSE